Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$24.92

$832 M

0.43%

$0.11

0.77%

Vitals

YTD Return

5.2%

1 yr return

11.4%

3 Yr Avg Return

12.6%

5 Yr Avg Return

10.9%

Net Assets

$832 M

Holdings in Top 10

70.9%

52 WEEK LOW AND HIGH

$24.8
$22.83
$26.37

Expenses

OPERATING FEES

Expense Ratio 0.77%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 32.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

$2,500


Fund Classification

Fund Type

Open End Mutual Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$24.92

$832 M

0.43%

$0.11

0.77%

FPHAX - Profile

Distributions

  • YTD Total Return 5.2%
  • 3 Yr Annualized Total Return 12.6%
  • 5 Yr Annualized Total Return 10.9%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.13%
DIVIDENDS
  • Dividend Yield 0.4%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name
    Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jun 18, 2001
  • Shares Outstanding
    N/A
  • Share Class
    No Load
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Karim Suwwan de Felipe

Fund Description

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.


FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.2% -80.8% 25.3% 61.68%
1 Yr 11.4% -28.4% 77.3% 89.95%
3 Yr 12.6%* -0.1% 33.4% 37.16%
5 Yr 10.9%* 2.1% 32.2% 81.82%
10 Yr 14.0%* 9.8% 21.9% 87.90%

* Annualized

Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2020 1.6% -13.6% 178.2% 91.33%
2019 21.0% 3.8% 63.8% 49.66%
2018 3.8% -49.7% 21.5% 8.03%
2017 8.9% -59.8% 54.4% 82.96%
2016 -17.2% -36.6% 11.6% 61.72%

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.2% -80.8% 25.3% 61.68%
1 Yr 11.4% -30.4% 77.3% 82.88%
3 Yr 12.6%* -15.9% 33.4% 37.43%
5 Yr 10.9%* -7.4% 32.2% 75.29%
10 Yr 14.0%* 9.8% 21.9% 85.07%

* Annualized

Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2020 1.6% -13.6% 178.2% 91.33%
2019 21.0% 3.8% 63.8% 49.66%
2018 4.4% -25.3% 22.2% 7.30%
2017 10.7% -10.8% 54.4% 88.15%
2016 -16.3% -36.6% 11.6% 69.53%

NAV & Total Return History


FPHAX - Holdings

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Assets 832 M 238 K 50.5 B 50.85%
Number of Holdings 66 11 477 56.54%
Net Assets in Top 10 628 M 2.18 K 21.1 B 28.27%
Weighting of Top 10 70.91% 8.6% 94.7% 2.53%

Top 10 Holdings

  1. AstraZeneca PLC ADR 11.65%
  2. Eli Lilly and Co 11.44%
  3. Sanofi SA ADR 8.91%
  4. Bristol-Myers Squibb Co 8.82%
  5. Roche Holding AG 7.50%
  6. Zoetis Inc Class A 4.95%
  7. Merck & Co Inc 4.81%
  8. Johnson & Johnson 4.76%
  9. Novartis AG ADR 4.69%
  10. Amgen Inc 3.81%

Asset Allocation

Weighting Return Low Return High FPHAX % Rank
Stocks
98.65% 83.68% 101.79% 62.03%
Cash
0.70% -0.82% 10.99% 45.15%
Other
0.65% -24.25% 9.11% 16.46%
Preferred Stocks
0.00% 0.00% 6.25% 40.08%
Convertible Bonds
0.00% 0.00% 0.10% 32.91%
Bonds
0.00% 0.00% 15.36% 35.86%

Stock Sector Breakdown

Weighting Return Low Return High FPHAX % Rank
Healthcare
100.00% 63.33% 100.00% 14.35%
Utilities
0.00% 0.00% 1.14% 32.91%
Technology
0.00% 0.00% 19.13% 38.82%
Real Estate
0.00% 0.00% 6.13% 36.71%
Industrials
0.00% 0.00% 7.02% 37.55%
Financial Services
0.00% 0.00% 1.92% 48.95%
Energy
0.00% 0.00% 0.80% 32.91%
Communication Services
0.00% 0.00% 7.81% 35.02%
Consumer Defense
0.00% 0.00% 28.21% 39.24%
Consumer Cyclical
0.00% 0.00% 16.95% 39.66%
Basic Materials
0.00% 0.00% 8.13% 49.79%

Stock Geographic Breakdown

Weighting Return Low Return High FPHAX % Rank
US
58.74% 57.23% 100.70% 99.58%
Non US
39.91% 0.00% 42.77% 1.27%

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.77% 0.08% 2.91% 46.15%
Management Fee 0.53% 0.00% 1.25% 27.93%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% 70.73%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 32.00% 0.00% 256.00% 25.45%

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank
Dividend Yield 0.43% 0.00% 2.44% 36.55%

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mod
Dividend Distribution Frequency Semi-Annually Annually Monthly Semi-Annually

Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Income Ratio 1.13% -2.54% 1.92% 6.32%

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually

Dividend Payout History

View More +

FPHAX - Fund Manager Analysis

Managers

Karim Suwwan de Felipe


Start Date

Tenure

Tenure Rank

Jul 01, 2017

4.25

4.3%

Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 24.06 6.71 1.46